A 'Bloody' Debate - Which Agent is Best to Prevent Stroke in a Treatment Naive Atrial Fribrillation Patient?

Monday, December 3, 2012
2:00 pm– 4:00 pm

Activity #: 204-000-12-250-L01P
Level of Content: Advanced
2.00 Contact Hours / Application-basedBC
Program Chair: Michael P. Gulseth, PharmD, BCPS, FASHP

Learning Objectives:

• Evaluate and pick an appropriate therapy for a patient who has new atrial fibrillation and needs a medication for stroke prophylaxis.
  
• Recommend what agent may be preferred in special patient populations (examples: renal dysfunction, interacting medications, etc.)for stroke prophylaxis in atrial fibrillation.
  
• Interpret the scientific literature supporting the approval of the agents used to prevent stroke in atrial fibrillation by identifying the strengths and weaknesses of each study.